Preferred Label : amphetamine;

MeSH definition : A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.;

MeSH synonym : phenamine; phenopromin; desoxynorephedrin; amfetamine;

CISMeF synonym : miquel brand of amfetamine sulfate;

MeSH hyponym : thyramine; mydrial; centramina; amphetamine sulfate; fenamine; Sulfate, Amphetamine; Amphetamine Sulfate (2:1);

Related MeSH term : l-Amphetamine; l Amphetamine; levo-Amphetamine; levo Amphetamine; Levoamphetamine;

MeSH CAS label : benzeneethanamine, alpha-methyl-, ( -)-;

MeSH Related Number : amphetamine sulfate; 300-62-9 (Amphetamine); 60-13-9 (Amphetamine sulfate); 60-15-1 (Amphetamine); 6DPV8NK46S;

Registry Number MeSH : 300-62-9;

Related CAS MeSH : 6DPV8NK46S (Amphetamine sulfate);

MeSH annotation : a specific chem: do not confuse with AMPHETAMINES; d-amphetamine DEXTROAMPHETAMINE; N-methylamphetamine METHAMPHETAMINE;

Wikipedia link : https://en.wikipedia.org/wiki/Amphetamine;

Codes EINECS : 206-096-2;

Is substance : O;

UNII : CK833KGX7E;

InChIKey : KWTSXDURSIMDCE-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.

http://www.cochrane.org/fr/CD007009
2010
United Kingdom
France
French
review of literature
attention deficit disorder with hyperactivity
Persons with Intellectual Disabilities
amphetamine
treatment outcome
central nervous system stimulants
french abstract

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/034000486.pdf
2003
false
France
French
france
substance-related disorders
age distribution
substance-related disorders
central nervous system stimulants
narcotics
hallucinogens
psychotropic drugs
health surveys
data collection
population characteristics
sex distribution
opioid-related disorders
injections
hiv infections
substance-related disorders
acquired immunodeficiency syndrome
hepatitis C
hepatitis B
injections
opioid-related disorders
heroin
opioid-related disorders
buprenorphine
buprenorphine
heroin dependence
amphetamine-related disorders
buprenorphine
buprenorphine
heroin
methadone
methadone
morphine
morphine
codeine
codeine
N-Methyl-3,4-methylenedioxyamphetamine
amphetamine
amphetamine-related disorders
cocaine-related disorders
crack cocaine
cocaine
cocaine-related disorders
cocaine
N-Methyl-3,4-methylenedioxyamphetamine
socioeconomic factors
hallucinogens
N-Methyl-3,4-methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
hallucinogens
hallucinogens
methamphetamine
methamphetamine
amphetamine
methamphetamine
amphetamine
central nervous system stimulants
central nervous system stimulants
lysergic acid diethylamide
lysergic acid diethylamide
lysergic acid diethylamide
ketamine
urban population
ketamine
ketamine
adult
flunitrazepam
psychotropic drugs
paris
trihexyphenidyl
Sex Work
alcoholism
marijuana smoking
substance-related disorders
sex workers
technical report

---
Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.